A recent study by Vanderbilt Health researchers has revealed a greater, detrimental role for B lymphocytes (B cells) in the ...
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics ...
Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...
As of Friday, January 23, Nektar Therapeutics’s NKTR share price has surged by 7.36%, which has investors questioning if this ...
T cells are central mediators of autoimmune disease pathogenesis, yet their functional states are not defined solely by antigen recognition or canonical ...
SAN DIEGO and SUZHOU, China, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company ...
Autoimmune diseases arise when the immune system mistakenly targets and damages the body’s cells and tissues as though they ...
Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
Researchers create Chinese Immune Multi-Omics Atlas, profiling more than 10 million immune cells and identifying 73 types of immune cells.
An existing therapy that boosts protective immune cells could reduce the likelihood of a repeat heart attack, Cambridge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results